Research Article

Hepatitis B and C Sero-prevalence in Patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome at a Tertiary Care Hospital in Izmir
  • Sabri ATALAY
  • Tuba TATLI KIŞ
  • Ufuk SÖNMEZ
  • Şükran KÖSE
Viral Hepat J 2018; 24: 3-6 DOI: 10.4274/vhd.0005
Seroprevalence of Hepatitis B Surface Antigen, Anti-Hepatitis B Surface and Anti-Hepatitis C Virus Among Pregnant Women Residing in Şırnak Province
  • Meyha ŞAHİN
  • Meltem ZENCİR
  • Alper Akın GÖZÜBÜYÜK
  • Bedri Aras PEKTAŞ
Viral Hepat J 2018; 24: 7-11 DOI: 10.4274/vhd.0010
The Efficiency of Hepatitis C Virus Core Antigen Test in the Diagnosis of Hepatitis C Infection
  • Mehmet Emin DEMİRCİLİ
  • Mehmet ÖZDEMİR
  • Bahadır FEYZİOĞLU
  • Bülent BAYSAL
Viral Hepat J 2016; 22: 18-22 DOI: 10.4274/vhd.78300
Should Hepatitis C Virus Antibody Be Used for Screening Purposes?
  • Birol ŞAFAK
  • Özge TOMBAK
  • Aynur EREN TOPKAYA
Viral Hepat J 2018; 24: 18-20 DOI: 10.4274/vhd.0018
Seroprevalance of Hepatitis B Virus, Hepatitis C Virus and Hepatitis D Virus in Healthy Blood Donors
  • Fatma SIRMATEL
  • Gülay YETKİN
  • Fatma Nur ERİŞ
  • Süda TEKİN KORUK
  • Fazilet DUYGU
  • Leman KARAAĞAÇ
  • Sevim DİNÇER
Viral Hepat J 2012; 18: 19-22 DOI: 10.4274/Vhd.18.05
Hepatitis C Virus Genotyping by Using Restriction Fragment Length Polymorphism (RFLP) in Anti-HCV Positive Hemodialysis Patients and Renal Transplant Recipients
Viral Hepat J 2005; 10: 28-33
The Relationship Between the Serum RNA Titers of Hepatitis C Virus and Biochemical Parameters in Chronic Hepatitis C Patients
  • Rukiye NAR
  • Fikriye MİLLETLİ SEZGİN
Viral Hepat J 2016; 22: 28-33 DOI: 10.4274/vhd.24008
ß2-Microglobulin Levels in Hepatitis C Virus Infection
  • Tamer SANLIDAG
  • Sinem AKÇALI
  • Ismail TOSUN
  • Beril ÖZBAKKALOGLU
Viral Hepat J 2005; 10: 37-40
Hepatitis C Prevalence in Different Age Groups; People Over 50 Years of Age May Receive One-Time Testing for Anti-HCV
  • Özlem AYDEMİR
  • Tayfur DEMİRAY
  • Mehmet KÖROĞLU
  • İhsan Hakkı ÇİFTÇİ
  • Ahmet ÖZBEK
  • Mustafa ALTINDİŞ
Viral Hepat J 2015; 21: 40-43 DOI: 10.4274/vhd.35220
The Frequency of Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus Infections among Patients with Schizophrenia in a Mental Health Hospital in Turkey
  • Nuran KARABULUT
Viral Hepat J 2016; 22: 48-51 DOI: 10.4274/vhd.38981
The Evaluation of the Seroprevalence of HBV and HCV Infections in Patients with Hemodialysisin Hatay City and the Assessment of Antibody Response to Hepatitis B Vaccination
  • Ömer EVİRGEN
  • Yusuf ÖNLEN
  • Vicdan KÖKSALDI MOTOR
  • Erkan MAHSERECİ
  • Melek İNCİ
  • Şule ŞAHİN
Viral Hepat J 2010; 16: 57-63
The Relationship Between Distribution of HCV-RNA and ALT-AST Levels with Genotypes of Hepatitis C Virus Infected Patients
  • Özlem KİRİŞÇİ
  • Ahmet ÇALIŞKAN
  • Sümeyra ALKIŞ KOÇTÜRK
  • Pınar ERDOĞMUS
  • Mustafa GÜL
Viral Hepat J 2013; 19: 67-70 DOI: 10.4274/Vhd.57966
Distribution of HCV Genotypes in Patients of with Chronic Hepatitis C in the Eastern Anatolia Region
  • Osman Aktaş
  • Ahmet Özbek
  • Hakan Aydın
  • Mehmet Beyhan Özkülekçi
Viral Hepat J 2014; 20: 91-94 DOI: 10.4274/vhd.41736
Interleukin 28B rs12979860 CT, rs12980275 GA, rs8099917 GT and TT genotypes are the Predictors of Rapid Viral Response in Hepatitis C Virus-Infected Patients
  • Aydin RÜSTEMOĞLU
  • Didem YALÇIN
  • Özgür GÜNAL
  • Betül ÇELİK
  • Şener BARUT
  • Ömer ATEŞ
Viral Hepat J 2016; 22: 97-102 DOI: 10.4274/vhd.51523
The Evaluation of HCV RNA, Serum Transaminases and AST/ALT Values of Anti-HCV Positive Patients
  • Tuba KAYMAN
  • Çiğdem KARAKÜKÇÜ
  • Ahmet GÖDEKMERDAN
Viral Hepat J 2013; 19: 99-102 DOI: 10.4274/Vhd.69885
Relationships between Serum ALT Levels, Anti-HCV and HCV RNA
  • Canan KÜLAH
  • Füsun BEGENDIK CÖMERT
  • Elif AKTAS
  • Nagehan ÖZLÜ
  • Zafer MENGELOGLU
Viral Hepat J 2007; 12: 116-120
HBsAg, Anti-Hepatitis C Virus and Anti-HIV Seroprevalence Among Patients Admitted to Our Hospital between 2005 and 2013
  • Havva Avcıküçük
  • Serap Süzük
  • Mehmet Kavak
Viral Hepat J 2014; 20: 125-130 DOI: 10.4274/vhd.29190
Intrafamilial Transmission of Hepatitis C Virus
  • Fatma HANEDAN
  • Fatih KÖKSAL
  • Canan AGLAR
  • Tuna DEMIRDAL
  • Çari ERGIN
  • Yunus GÜRBÜZ
  • Rüçhan TÜRKYILMAZ
Viral Hepat J 2004; 9: 135-139

Clinical Investigation

Evaluation of Paraoxonase 1 Activities in Patients Infected with Hepatitis C Virus Genotype 1b and Genotype 4 in the Kayseri Province of Turkey
  • Fatma Mutlu SARIGÜZEL
  • Çiğdem KARAKÜKCÜ
  • Derya KOÇER
  • Hatice KARAMAN
  • Ahmet KARAMAN
  • Ozan YAMAN
  • Ahmet GÖDEKMERDAN
Viral Hepat J 2015; 21: 13-16 DOI: 10.4274/vhd.65256

Letter to Editor

How to Diagnosis the Occult Hepatitis C Virus?
  • Ferhat Gürkan ASLAN
  • Mustafa ALTINDİŞ
Viral Hepat J 2017; 23: 37-38 DOI: 10.4274/vhd.55264
Seroprevalence of Hepatitis B Virus, Hepatitis C Virus and HIV among Health Care Staff in a State Hospital
  • Handan ALAY
  • Neslihan ÇELİK
  • Berrin GÖKTUĞ KADIOĞLU
  • Esra ÇINAR TANRIVERDİ
  • Emine PARLAK
  • Fatma BATTAL MUTLU
  • Zülal ÖZKURT
Viral Hepat J 2016; 22: 62-64 DOI: 10.4274/vhd.54154
Seroprevalence Rates of Hepatitis B Surface Antigen, Anti-Hepatitis C Virus and Anti-Human Immunodeficiency Virus ½ Certain Risk Groups
  • Tayfur DEMİRAY
  • Kerem YILMAZ
  • Mehmet KÖROĞLU
  • Mustafa ALTINDİŞ
Viral Hepat J 2016; 22: 65-66 DOI: 10.4274/vhd.19480
Hepatitis B Virus and Hepatitis C Virus Seroprevalence in Hemodialysis Patients in Eskisehir Yunus Emre State Hospital
  • Pınar Korkmaz
  • Figen Çağlan Çevik
  • Nevil Aykın
  • Rüya Mutluay
  • Hakkı Mustafa Güldüren
  • Yeşim Alpay
  • Zühre Doğru Yaşar
  • Melahat Uğur
Viral Hepat J 2014; 20: 140-141 DOI: 10.4274/vhd.47955

Review

Improvement and New Aspects of HCV Testing for Clinical Management
  • Mehmet ÖZDEMİR
  • Mustafa ALTINDİŞ
Viral Hepat J 2013; 19: 93-98 DOI: 10.4274/Vhd.62634

Other

THE DISTRIBUTION OF HEPATITIS C VIRUS (HCV) GENOTYPES IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
  • Ali HAFTA
  • Fügen YARKIN
Viral Hepat J 2000; 6: 0-0
DETERMINATING THE HEPATITIS B AND HEPATITIS C SEROPREVALANCE OF THE BARBERS IN KIRIKKALE CITY
  • Dilek KILIÇ
  • R. Cenap YILDIRIM
  • Teoman Z. APAN
Viral Hepat J 2000; 6: 0-0
SEROPREVALANCE OF HBsAg, ANTI-HBs AND ANTI-HCV IN SANLIURFA
  • Gönül ASLAN
  • Mustafa ULUKANLIGIL
  • Adnan SEYREK
Viral Hepat J 2001; 7: 0-0
Comparasion of a commercial assay (Amplicor HCV) with nested PCR in the diagnosis of hepatitis C virus infection
  • Salih TÜRKOGLU
  • Mürvet BOZACI
  • Banu Bayraktar
  • Ayfer Ataysaggin
  • Selim BADUR
Viral Hepat J 1996; 1: 0-0
Seroprevalence of HBV and HCV in Patients with Chronic Disease
  • Irfan SENCAN
  • Idris SAHIN
  • Yasar SERTBAS
  • Öner BALBAY
  • Ismet BULUT
Viral Hepat J 2003; 8: 0-0
The Evaluation of Three Years Results of HBV and HCV Serological Markers in Our Hospital
  • Mehmet ÖZDEN
  • Kutbettin DEMIRDAG
  • Ahmet KALKAN
Viral Hepat J 2003; 8: 0-0
Prevalance of HBsAg, Anti-HBs, Anti-HBc Total, Anti-HBc IgM, Anti-HCV andAnti-HAV IgG in Hemodialysis Patients
  • Ayten KADANALI
  • Suna PIRIMOGLU
  • Kemalettin ÖZDEN
Viral Hepat J 2004; 9: 41-45
HBsAg, Anti-HCV and Anti-HIV Seropositivity in Women Aged Between 18 and 45 Years
  • Mehmet S. TEKEREKOGLU
  • Elif AKTAS
  • Ibrahim H. ÖZEROL
  • Riza DURMAZ
Viral Hepat J 2004; 9: 46-49
Intrafamillial Transmission of Hepatitis C Virus Infection
  • Aysegül H. ÖZAKYOL
  • Hasan YAVUZ
  • Tülay SARIÇAM
  • Eser VARDARELI
  • Zafer GÜLBAS
  • Esat ERENOGLU
Viral Hepat J 1999; 5: 69-71
Kronik akci¤er hastal›¤›, hepatit B viru¨su¨, hepatit C viru¨su¨, nozokomiyal geçifl.
  • Sener BARUT
  • Serpil ÖCAL
  • Ayse YILMAZ
  • Handan INÖNÜ
  • Ünal ERKORKMAZ
  • Özcan AVCI
Viral Hepat J 2006; 11: 70-75
Hepatitis C Virus Infection Incidences in Patients with Chronic Obstructive Pulmonary Disease
  • Mustafa ALTINDIS
  • Ayse ORMAN
  • Mehmet ÜNLÜ
  • Yücel KIRLANGIÇ
Viral Hepat J 2004; 9: 76-81
The Seroprevalence of Hepatitis C virus (HCV) in HIV infected Patients and Blood Donors
  • Muzaffer FINCANCI
  • Ayse Gül MUTLU
  • Özcan NAZLICAN
  • Dilek MAMÇU
Viral Hepat J 1995; 1: 94-96
A Case of Erythema Multiforme Related to Pegylated Interferon-a2a Plus Ribavirin Treatment for Chronic Hepatitis C Virus Infection
  • Ilhan ÖZGÜNES
  • Elif DOYUK KARTAL
  • Nurettin ERBEN
  • Saygin NAYMAN ALPAT
  • Gaye USLUER
Viral Hepat J 2006; 11: 101-104
Seroprevalence of Anti-HAV, HBsAg, Anti-HBs and Anti-HCV According to Age and Sex in K›r›kkale
  • Sedat KAYGUSUZ
  • Dilek KILIÇ
  • Ergin AYASLIOGLU
  • Özlem ÖZLÜK
  • Levent CERIT
  • Aysenur YILDIRIM
Viral Hepat J 2003; 8: 160-165
Hepatit C Virus Seroprevalence Central and Rural Areas of Erzurum
  • Servet KÖLGELIER
  • Mustafa ERTEK
  • Serpil EROL
  • Mehmet A. TASYARAN
Viral Hepat J 2003; 8: 166-170
IS HCV INFECTION AN ADDITIONAL RISK FACTOR FOR DEVELOPMENT OF TYPE-2 DIABETES
  • O. ÖNCÜL
  • C. TOP
  • S. ÇAVUSLU
Viral Hepat J 2002; 8: 436-440

About Journal

Forms

Useful Links

Applications